SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00079



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00079_DPrep1 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep2 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep3 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep4 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep5 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DQrep1 19 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep2 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep3 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep4 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep5 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep6 16 Human HLA-DQA10505-DQB10301
SYSMHC00079_DRrep1 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep2 8 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep3 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep4 16 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep5 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep6 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep7 31 Human DRB1_1201,DRB3_0202



Detailed view of sample SYSMHC00079_DRrep7



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A10.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 1
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A11.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 2
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A12.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 3
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A13.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 4
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A14.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 5
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A15.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 6
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A3.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 7
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A4.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 8
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A5.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 9
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A6.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 10
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A7.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 11
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A8.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 12
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A9.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 13
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B10.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 14
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B11.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 15
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B12.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 16
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B13.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 17
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B14.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 18
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B15.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 19
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B1.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 20
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B2.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 21
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B3.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 22
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B4.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 23
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B5.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 24
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B6.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 25
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B8.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 26
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B9.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 27
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C1.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 28
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C2.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 29
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C3.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 30
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C4.wiff Human In vitro Blood Lymphoblast cell suspension EBV transformed class II DRB1_1201,DRB3_0202 PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 31